Legal & General Group PLC Fulcrum Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 6,520 shares of FULC stock, worth $19,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,520

Previous 6,520 -0.0%

Holding current value

$19,625

Previous $23,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.18 - $9.74 $1,653 - $5,064	520 Added 8.67%	6,520 $23,000
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $35,880 - $55,860	6,000 New	6,000 $37,000
Q1 2023 May 15, 2023	SELL	$2.83 - $13.99 $12,534 - $61,961	-4,429 Reduced 31.81%	9,496 $27,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $5,340 - $8,901	1,066 Added 8.29%	13,925 $101,000
Q3 2022 Nov 14, 2022	SELL	$4.92 - $9.1 $21,943 - $40,586	-4,460 Reduced 25.75%	12,859 $104,000
Q2 2022 Aug 22, 2022	BUY	$4.2 - $24.0 $4,162 - $23,784	991 Added 6.07%	17,319 $85,000
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $19,222 - $45,644	-1,930 Reduced 10.57%	16,328 $385,000
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $225,806 - $458,708	16,129 Added 757.59%	18,258 $323,000
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $2,649 - $11,273	364 Added 20.62%	2,129 $60,000
Q2 2021 Aug 12, 2021	SELL	$8.09 - $12.0 $1,156 - $1,716	-143 Reduced 7.49%	1,765 $18,000
Q1 2021 May 17, 2021	BUY	$10.94 - $15.32 $3,653 - $5,116	334 Added 21.22%	1,908 $22,000
Q3 2020 Nov 13, 2020	SELL	$7.22 - $20.7 $3,393 - $9,729	-470 Reduced 22.99%	1,574 $12,000
Q2 2020 Aug 14, 2020	BUY	$9.11 - $22.06 $956 - $2,316	105 Added 5.42%	2,044 $37,000
Q1 2020 May 14, 2020	BUY	$9.49 - $21.26 $8,645 - $19,367	911 Added 88.62%	1,939 $25,000
Q4 2019 Feb 13, 2020	BUY	$4.46 - $18.14 $677 - $2,757	152 Added 17.35%	1,028 $17,000
Q3 2019 Nov 13, 2019	BUY	$6.64 - $14.89 $5,816 - $13,043	876 New	876 $6,000

Others Institutions Holding FULC

# of Institutions

150

Shares Held

52.2M

Call Options Held

6.91M

Put Options Held

1.9M

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $157M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Fulcrum Therapeutics, Inc. Transaction History